To interrogate the possibility that KAT2A and KAT2B are functionally redundant in this context, we used two MYCN-amplified neuroblastoma cell lines, KELLY and NB1, that depend on TADA2B but have high and low KAT2B expression, respectively (Fig. 6, B and C). The gene discussed is KAT2A; the disease is neuroblastoma.